| 1 |
35418130 | Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells. | 2022 Apr 13 |
1 |
| 2 |
35547095 | Current status and advances of immunotherapy in nasopharyngeal carcinoma. | 2022 |
2 |
| 3 |
33376237 | Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma. | 2020 Dec 30 |
1 |
| 4 |
31470128 | Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC. | 2019 Dec |
1 |